From endometriosis and cervical cancer, to diabetes, vitamin D deficiency and pollution exposure, scientists are finding ...

University of Edinburgh spin-out BIOCAPTIVA has raised £1.58 million in a new funding round and launched its first product in the US.BIOCAPTIVA’s a novel magnetic bead technology is designed to solve ...

Researchers created an AI-driven liquid biopsy that scans patterns in fragments of DNA circulating in the blood. The system detected early liver fibrosis and cirrhosis—conditions that often go ...

Heterotopic ossification (HO) is a common post-surgery condition where bone abnormally forms within soft tissues. A new study out of Mass General Brigham assesses the viability of a simple blood test ...

A grandad-of-two was diagnosed with a life-threatening blood cancer after feeling "unusually tired." Harish Nersian, 73, went ...

The first-of-its-kind procedure, performed on a four-year-old, is part of the Department of Health – Abu Dhabi’s Visiting Physicians Programme ...

Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...

Global Liquid Biopsy Market OverviewThe global liquid biopsy market is anticipated to register a strong compound annual growth rate of around 17% through 2031, driven by the increasing global burden ...

Procedure at Sheikh Khalifa Medical City allows young transplant patients to undergo follow-up care locally instead of travelling abroad ...

Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test ...

University of Edinburgh spin-out BIOCAPTIVA secures £1.58m funding and launches its msX liquid biopsy technology in the US to improve cancer diagnostics and research.

Research team at OncoRay identifies MMP11 as a promising biomarker for liquid biopsy in prostate cancer Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In ...